Christopher Taylor
Contacto de Relaciones con Inversores en AGIOS PHARMACEUTICALS, INC. .
Cargos activos de Christopher Taylor
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | - | - |
| Public Communications Contact | - | - |
Historial de carrera de Christopher Taylor
Antiguos cargos conocidos de Christopher Taylor.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CODIAK BIOSCIENCES | Contacto de Relaciones con Inversores | 01/12/2020 | 01/06/2023 |
| Public Communications Contact | 01/12/2020 | 01/06/2023 | |
| ALAUNOS THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/03/2019 | - |
| Public Communications Contact | 01/03/2019 | - |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Taylor
- Experiencia
